scholarly journals The Role of Culture Collections in the Era of Molecular Biology.: ATCC 50th Aniversary Symposium Held 23 September 1975 in Washington, D.C. Edited by Rita R. Colwell. American Society for Microbiology, Washington, D.C., 1976, 76 p., $12.

1976 ◽  
Vol 26 (3) ◽  
pp. 340-340
Author(s):  
P. H. A. SNEATH
Keyword(s):  
Molecular Biology ◽  
Culture Collections ◽  
American Society ◽  
American Society For Microbiology

scholarly journals Role of Clinicogenomics in Infectious Disease Diagnostics and Public Health Microbiology

2016 ◽  
Vol 54 (7) ◽  
pp. 1686-1693 ◽  
Author(s):  
Lars F. Westblade ◽  
Alex van Belkum ◽  
Adam Grundhoff ◽  
George M. Weinstock ◽  
Eric G. Pamer ◽  
...  
Keyword(s):  
Public Health ◽  
Infectious Disease ◽  
Sequence Data ◽  
General Meeting ◽  
Disease Diagnostics ◽  
Infectious Disease Diagnostics ◽  
High Throughput Dna Sequencing ◽  
American Society ◽  
American Society For Microbiology

Clinicogenomics is the exploitation of genome sequence data for diagnostic, therapeutic, and public health purposes. Central to this field is the high-throughput DNA sequencing of genomes and metagenomes. The role of clinicogenomics in infectious disease diagnostics and public health microbiology was the topic of discussion during a recent symposium (session 161) presented at the 115th general meeting of the American Society for Microbiology that was held in New Orleans, LA. What follows is a collection of the most salient and promising aspects from each presentation at the symposium.

scholarly journals Application, Verification, and Implementation of SARS-CoV-2 Serologic Assays with Emergency Use Authorization

2020 ◽  
Vol 59 (1) ◽  
pp. e02148-20 ◽  
Author(s):  
Elitza S. Theel ◽  
Marc Roger Couturier ◽  
Laura Filkins ◽  
Elizabeth Palavecino ◽  
Stephanie Mitchell ◽  
...  
Keyword(s):  
Quality Control ◽  
Testing Strategies ◽  
Clinical Microbiologist ◽  
Antibody Class ◽  
American Society ◽  
American Society For Microbiology ◽  
Prior Infection ◽  
The U.S ◽  
Expert Recommendations

ABSTRACTInterest continues to grow regarding the role of serologic assays for the detection of prior infection with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). The U.S. Food and Drug Administration (FDA) has granted emergency use authorization (EUA) status to many SARS-CoV-2 serologic assays. In this document, expert recommendations from clinical microbiologist members of the American Society for Microbiology (ASM) concerning detailed verification strategies for SARS-CoV-2 serologic assays with FDA EUA are provided, as are insights into assay limitations and reporting considerations for laboratories. Assessments concerning single-antibody and multiantibody isotype detection assays, which may provide either differentiated or nondifferentiated (i.e., total antibody) antibody class results, are addressed. Additional considerations prior to assay implementation are also discussed, including biosafety, quality control, and proficiency testing strategies. As the landscape of SARS-CoV-2 serologic testing is rapidly changing, this document provides updated guidance for laboratorians on application of these assays.

Sign in / Sign up

Export Citation Format

Share Document